BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36781808)

  • 1. Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.
    Taylor DB; Burrows S; Saunders CM; Parizel PM; Ives A
    Eur Radiol Exp; 2023 Feb; 7(1):8. PubMed ID: 36781808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
    Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
    Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
    Åhsberg K; Gardfjell A; Nimeus E; Ryden L; Zackrisson S
    BMC Cancer; 2021 Oct; 21(1):1115. PubMed ID: 34663236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of MRI-Directed Contrast-Enhanced Mammography for Biopsy Planning for Suspicious MRI-Detected Breast Lesions.
    Nida BA; Rooney TB; Miller MM
    AJR Am J Roentgenol; 2023 Feb; 220(2):202-211. PubMed ID: 36000664
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective.
    Lobbes MBI; Heuts EM; Moossdorff M; van Nijnatten TJA
    Eur J Radiol; 2021 Sep; 142():109883. PubMed ID: 34358810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging.
    Terzoni A; Basile P; Gambaro AC; Attanasio S; Rampi AM; Brambilla M; Carriero A
    Radiol Med; 2024 Apr; 129(4):558-565. PubMed ID: 38512618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
    Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
    J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study.
    Åhsberg K; Gardfjell A; Nimeus E; Rasmussen R; Behmer C; Zackrisson S; Ryden L
    World J Surg Oncol; 2020 May; 18(1):100. PubMed ID: 32438917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term follow-up of contrast-enhanced mammography lesions after negative breast MRI in women with elevated breast cancer risk.
    Coffey K; Dixon LB; Sevilimedu V; Jochelson MS; Sung JS
    Eur J Radiol; 2023 Nov; 168():111097. PubMed ID: 37738835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multireader comparison of contrast-enhanced mammography versus the combination of digital mammography and digital breast tomosynthesis in the preoperative assessment of breast cancer.
    Girometti R; Linda A; Conte P; Lorenzon M; De Serio I; Jerman K; Londero V; Zuiani C
    Radiol Med; 2021 Nov; 126(11):1407-1414. PubMed ID: 34302599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Targeted Ultrasound to Predict Malignancy Among Lesions Detected on Contrast-Enhanced Digital Mammography.
    Coffey K; Sung J; Comstock C; Askin G; Jochelson MS; Morris EA; D'Alessio D
    AJR Am J Roentgenol; 2021 Sep; 217(3):595-604. PubMed ID: 33025811
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening.
    Lawson MB; Partridge SC; Hippe DS; Rahbar H; Lam DL; Lee CI; Lowry KP; Scheel JR; Parsian S; Li I; Biswas D; Bryant ML; Lee JM
    Radiology; 2023 Aug; 308(2):e230576. PubMed ID: 37581498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEM immediately after contrast-enhanced CT: a one-step staging of breast cancer.
    Ancona A; Telegrafo M; Fella RR; Iamele D; Cantore S; Moschetta M
    Eur Radiol Exp; 2024 Apr; 8(1):32. PubMed ID: 38556593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer.
    Lobbes MBI; Neeter LMFH; Raat F; Turk K; Wildberger JE; van Nijnatten TJA; Nelemans PJ
    Eur J Radiol; 2023 Jul; 164():110881. PubMed ID: 37201248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia.
    Nicosia L; Rotili A; Pesapane F; Bozzini AC; Battaglia O; Pellegrino G; Fusco N; Porta FM; Frassoni S; Bagnardi V; Corso G; Sangalli C; Cassano E
    Breast Cancer Res Treat; 2024 Jan; 203(1):135-143. PubMed ID: 37787819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
    Pötsch N; Vatteroni G; Clauser P; Helbich TH; Baltzer PAT
    Radiology; 2022 Oct; 305(1):94-103. PubMed ID: 36154284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
    Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
    Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study.
    Bernardi D; Vatteroni G; Acquaviva A; Valentini M; Sabatino V; Bolengo I; Pellegrini M; Fantò C; Trimboli RM
    AJR Am J Roentgenol; 2022 Dec; 219(6):884-894. PubMed ID: 35731101
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamic contrast-enhanced mammography and breast MRI in the diagnosis of breast cancer and detection of tumor size.
    Tekinhatun M; Sabir N; Erdem E; Yilmaz S; Ufuk F
    Turk J Med Sci; 2024; 54(1):249-261. PubMed ID: 38812642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of contrast-enhanced mammography in the preoperative evaluation of invasive lobular carcinoma of the breast.
    Giannotti E; Van Nijnatten TJA; Chen Y; Bicchierai G; Nori J; De Benedetto D; Lalji U; Lee AHS; James J
    Clin Radiol; 2024 Jun; 79(6):e799-e806. PubMed ID: 38383254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.